Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
CompletedOBSERVATIONAL
Enrollment
58
Participants
Timeline
Start Date
December 2, 2019
Primary Completion Date
January 31, 2020
Study Completion Date
January 31, 2020
Conditions
Stage I Pulmonary Adenocarcinoma
Trial Locations (1)
20132
IRCCS San Raffaele, Milan
All Listed Sponsors
lead
IRCCS San Raffaele
OTHER
NCT04202614 - Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma | Biotech Hunter | Biotech Hunter